Sort
21,453 grants matching “tuberculosis”
Hijacking Plasmodium ubiquitin-proteasome system to defeat drug resistance
$749,775Gang Lin · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
Tuberculosis Immunopathogenesis During Superinfection with SARS-CoV2
$749,747Adel M Talaat · University Of Wisconsin-Madison · R01 · FY2025 · AI
International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.
$749,723Eliane Rohner · Universitat Bern · U01 · FY2025 · AI
Preclinical development of teixobactin, a new antibiotic
$749,698Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2015 · AI
Human immune signatures of natural immunity to DENV infection, severe disease, and vaccination with attenuated live vaccine
$749,544Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2016 · AI
A Computer Modeling Approach
$749,499Karen Joy Shaw · Amplyx Pharmaceuticals, Inc. · R44 · FY2015 · NS
Identifying Optimal Treatment Strategies for Tuberculosis Treatment
$749,427Radojka Savic · University Of California, San Francisco · R01 · FY2021 · AI
Mechanism of macrophage efflux system in Mycobacterium tuberculosis pathogenesis
$749,414Murugesan Rajaram · Ohio State University · R56 · FY2024 · AI
Myocardial Fibrosis and Steatosis Burden and Region-Specific Predictors of Progression among ART-treated Women with HIV infection in sub-Saharan Africa (The MUTIMA Study)
$749,390Chris Todd Longenecker · University Of Washington · R01 · FY2023 · HL
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin
$749,232Huimin Zhao · University Of Illinois At Urbana-Champaign · R01 · FY2020 · AI
IeDEA West Africa Renewal 3
$749,211Francois Dabis · Adera · U01 · FY2017 · AI
Molecular basis of BCG vaccine sub-strain heterogeneity
$749,192Jeffrey D. Cirillo · Texas A&M University Health Science Ctr · R01 · FY2025 · AI
Therapeutic vaccination to augment stringent response-specific T-cell immunity to MTB persisters
$749,043Petros C Karakousis · Johns Hopkins University · R01 · FY2022 · AI
Linking the behavior of individual host cells to their transcriptional signatures
$749,034Lalita Ramakrishnan · University Of Washington · DP1 · FY2013 · MH
Integrative Pharmacology Approach to Understand Mechanisms of TB Drug Resistance
$748,871Eric L Nuermberger · Johns Hopkins University · R01 · FY2017 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$748,653Jon Tillinghast · Oklahoma State Department Of Health · U52 · FY2007 · PS
Structure/Function of Transcription Complex Regulation
$748,437Robert Landick · University Of Wisconsin-Madison · R01 · FY2019 · GM
Structure/Function of Transcription Complex Regulation
$748,437Robert Landick · University Of Wisconsin-Madison · R01 · FY2020 · GM
Deep sequencing of pathogens to precisely define transmission networks using rare variants
$748,381William Hanage · Harvard School Of Public Health · R01 · FY2018 · AI
Hospital and Household Studies of Respiratory Cryptosporidiosis and Transmission
$748,322Jeffrey K Griffiths · Tufts University Boston · R01 · FY2012 · AI
C-type Lectin Receptor Pathways in the Pathogenesis of TB/HIV Co-infection
$748,275Janice J Endsley · University Of Texas Med Br Galveston · R61 · FY2018 · AI
A Scalable Platform to Discover Antimicrobials of Ribosomal Origin
$748,142Huimin Zhao · University Of Illinois At Urbana-Champaign · R01 · FY2021 · AI
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
$747,934Satish Gopal · Univ Of North Carolina Chapel Hill · U54 · FY2014 · CA
Reimagining the IMAGINE-TBM trial: Using metagenomics and host transcriptomics to improve our ability to diagnose tuberculous meningitis and assess response to treatment in a randomized clinical trial
$747,881Felicia C. Chow · University Of California, San Francisco · R01 · FY2025 · NS
A Cytomegalovirus-based Vaccine Targeting the Pre-erythrocytic Stage of Malaria
$747,848Klaus J Frueh · Oregon Health & Science University · R01 · FY2020 · AI